Background Image
Table of Contents Table of Contents
Previous Page  42 / 68 Next Page
Information
Show Menu
Previous Page 42 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 3, May/June 2015

140

AFRICA

Prevalence of anaemia among patients with heart failure

at the Brazzaville University Hospital

Méo Stéphane Ikama, Bernice Mesmer Nsitou, Innocent Kocko, Ngamami Solange Mongo, Gisèle

Kimbally-Kaky, Jean Louis Nkoua

Abstract

Background:

Heart failure (HF) is a frequent cause of hospi-

talisation in cardiology. Its prognosis depends on several risk

factors, one of which is anaemia.

Objectives:

We aimed to determine the prevalence of anaemia

in patients with heart failure, and evaluate its impact on their

prognosis.

Methods:

This article describes a cross-sectional study with

prospective collection of data, carried out from 1 January

to 31 December 2010 in the Department of Cardiology at

Brazzaville University Hospital, Congo. Patients admitted

for heart failure were included. Anaemia was defined as a

haemoglobin level

<

12 g/dl for men and

<

11 g/dl for women.

Results:

In total, 130 men (47.8%) and 142 women (52.2%)

were recruited, mean age 56.9

±

16.5 years. The prevalence of

anaemia was 42%. Average levels of haemoglobin were 9.4

±

1.8 and 13.8

±

4.9 g/dl for the anaemic (A) and non-anaemic

(NA) patients, respectively (

p

=

0.0001). Two hundred and

forty-nine patients (91.5%) were in NYHA functional class

III–IV. Forty-seven patients (17.3%) were on oral anticoagula-

tion and 15 (5.5%) were on aspirin. The average duration of

hospital stay was 19.1

±

16.7 days, without a significant differ-

ence between the A and NA groups (19.4

±

12 vs 18.8

±

13.8

days;

p

=

0.79, respectively). Total mortality rate was 17%,

with a significant difference between the A and NA groups

(26 vs 10%;

p

=

0.001).

Conclusion:

This preliminary study showed a high prevalence

of anaemia in patients with heart failure, and it had a negative

effect on the prognosis.

Keywords:

heart failure, anaemia, prevalence, prognosis, Congo

Submitted 27/7/14, accepted 3/2/15

Cardiovasc J Afr

2015;

26

: 140–142

www.cvja.co.za

DOI: 10.5830/CVJA-2015-021

Heart failure (HF) is a frequent cause of hospitalisation in

cardiology. Its prognosis depends on several factors, including

anaemia, which is common among patients with heart failure.

1

Anaemia is an independent prognostic factor for mortality in

chronic HF and is associated with higher rates of mortality,

hospitalisation and re-admission.

2,3

Anaemia is a powerful

independent predictor of death and hospitalisation in systolic

and diastolic dysfunction.

2,4-7

In order to improve the management of patients suffering

from systolic and diastolic HF, it is critical to understand

the relationship between HF and anaemia, and the possible

outcomes. The aim of this study was to determine the prevalence

of anaemia in patients with heart failure and to evaluate its

impact on the prognosis of patients in Brazzaville, Congo.

Methods

This article describes a cross-sectional study with a prospective

approach to data collection, carried out from 1 January to 31

December 2010 in the Department of Cardiology and Internal

Medicine at Brazzaville University Hospital. The study included

patients admitted for left or biventricular heart failure. Patients

admitted for exclusively right heart failure, or a cause other than

heart failure, as well as for sickle anaemia, were excluded.

Anaemia was defined as a haemoglobin level

<

12 g/dl for men

and

<

11 g/dl for women. Two hundred and seventy-two patients

were selected and divided into two groups according to anaemic

status: anaemic (

n

=

114) and non-anaemic patients (

n

=

158).

Socio-demographics such as age, gender and socio-economic

level were analysed, as well as clinical and echocardiographic

parameters, including type of heart failure (left or biventricular),

NYHA (New York Heart Association) functional class, the use

of aspirin and/or oral anticoagulation, type of heart disease, and

left ventricular ejection fraction (LVEF). In addition, we studied

blood profiles, including haemoglobin level, renal function

(estimated by glomerular filtration rate using the Cockroft–

Gault equation; considered to be lowered if GFR

<

60 ml/min).

Finally, we analysed prognosis in terms of duration of hospital

stay, and mortality rate (outcome for that same admission).

Statistical analysis

The data were analysed with Epi-info 3.5.1 software. The

chi-squared and ANOVA tests allowed the comparison of

qualitative and quantitative variables, respectively. The

significance level was

p

<

0.05.

Results

A total of 272 patients were evaluated, including 130 men

(47.8%) and 142 women (52.2%), with a mean age of 56.9

±

16.5

years (range: 18–97). The prevalence of anaemia was 42%, with

an average haemoglobin level of 11.9

±

4.4 g/dl (range: 4.7–15.2).

Cardiologie, CHU de Brazzaville, Brazzaville, Congo

Méo Stéphane Ikama, MD,

stephane.mikama@gmail.com

Bernice Mesmer Nsitou, MD

Ngamami Solange Mongo, MD

Gisèle Kimbally-Kaky, PhD

Jean Louis Nkoua, PhD

Hématologie clinique, CHU de Brazzaville, Brazzaville, Congo

Innocent Kocko, MD